MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Activity
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

62 hedge funds and large institutions have $56.5M invested in Mirati Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
-7
Holders Change %
-10.14%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
21
Reduced
19
Closed
14
Calls
$2K
Puts
$85K
Net Calls
-$83K
Net Calls Change
-$86K

Top Buyers

1
GPP
Great Point Partners
Connecticut
$4.13M
2
Millennium Management
Millennium Management
New York
$766K
3
PAM
Panagora Asset Management
Massachusetts
$324K
4
BFA
BlackRock Fund Advisors
California
$1.9M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
$238K

Top Sellers

1
Franklin Resources
Franklin Resources
California
$1.79M
2
Vanguard Group
Vanguard Group
Pennsylvania
$2.49M
3
BC
Broadfin Capital
New York
$3.92M
4
ACP
Acuta Capital Partners
California
$0
5
Renaissance Technologies
Renaissance Technologies
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Zurich Cantonal Bank
76
Zurich Cantonal Bank
Switzerland
– -$2K -365 Closed
1 2 3
4